4-5

Caplin Point Laboratories Ltd generate over US$50 million in revenue annually with a healthy bottom line. We have recently been selected by Forbes Asia magazine as one of the Top 200 best performing companies in Asia, for the second time in a row. Caplin is the only Pharma company in India to be selected in both 2014 and 2015. We have been manufacturing, exporting and distributing our products to Latin America and Africa for the last 16 years and we're already in the Top 5 exporters from India to Latin America over the last few years.

Sun Parma is the fifth largest generic pharmaceutical company in the world. It is also India's largest and most valuable pharmaceutical enterprise by site and market capitalization. The company provides high-quality medicines trusted by customers and patients in over ISO countries and has multiple manufacturing facilities and R & D centres. Ox leadership is approachable, recognizes people's passion for growth, gives them a voice and empowers them to make a positive change. To keep pace with our growth plans, we require for our Formulation manufacturing plant at DADRA. U.T. of D. & N. H.

Post : Officer / Sr. Officer / Executive

Syngene International is one of India’s premier contract research and manufacturing organizations in providing customized service. Our services encompasses all across discovery chain: early stage discovery, process development, cGMP manufacturing and formulation development both in the small molecule and novel biologics area. Based in Bangalore, Karnataka, the Company is situated in a 90 acre Special Economic Zone with over 100000 sq. mt of built up facilities.

Post : Quality Control Specialist

BDH Industries Limited is an Export Oriented Dynamic & Growing Public Limited, Pharmaceutical Company, Exporting Pharmaceutical Formulation to more than 20 countries since last seven decades.

Post : Quality Assurance : Manager / Deputy Manager

Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post : Scientist 1

Teva is a global pharmaceutical leader and the world’s largest generic medicines producer, committed to improving health and increasing access to quality health solutions worldwide.  Our employees are at the core of our success, with colleagues in over 80 countries delivering the world’s largest medicine cabinet to 200 million people every day. We offer a uniquely diverse portfolio of products and solutions for patients and we’ve built a promising pipeline centered around our core therapeutic areas.  We are continually developing patient-centric solutions and significantly growing both our generic and specialty medicines business through investment in research and development, marketing, business development and innovation.

Post : Analytical Researcher I

Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post : Global Program Regulatory Director

Indoco Remedies Ltd. headquartered in India, is a fast growing, fully integrated, research oriented pharmaceutical company with a Global presence, Indoco manufactures a wide range of pharmaceutical products in various therapeutic segments for Indian and International markets.

Post : Production Supervisor/Operator- Api Manufacturing

The Dr. Reddy's Institute of Life Sciences was conceived in the context of globalization, to foster research competence in India and to bridge the divide between academic research and the pharmaceutical & biotechnology industries.  The institute was incorporated as a non-profit entity under Section 25 of the Indian companies act, facilitating operational autonomy. Construction of the DRILS building comprising 44 labs and an administrative block and spanning ~130,000 sq.ft. in area, began in 2004 and was completed in January 2007.